Adrian Kilcoyne
Chief Tech/Sci/R&D Officer en CELULARITY INC. .
Fortuna: 586 932 $ al 31/03/2024
Perfil
Adrian Kilcoyne is currently the Chief Medical Officer & Executive Vice President at Celularity, Inc. Prior to this, he worked as the VP, Head-US Medical Affairs & Health Economics at AstraZeneca PLC.
He also served as the Chief Medical Officer at Humanigen, Inc. from 2021 to 2022.
Dr. Kilcoyne has a graduate degree from Warwick Business School and the University of London.
He also holds a doctorate degree from Trinity College Dublin.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
CELULARITY INC. CLASS A
0.52% | 17/02/2024 | 112 224 ( 0.52% ) | 586 932 $ | 31/03/2024 |
Cargos activos de Adrian Kilcoyne
Empresas | Cargo | Inicio |
---|---|---|
CELULARITY INC. | Chief Tech/Sci/R&D Officer | 03/10/2022 |
Antiguos cargos conocidos de Adrian Kilcoyne.
Empresas | Cargo | Fin |
---|---|---|
HUMANIGEN, INC. | Chief Tech/Sci/R&D Officer | 28/09/2022 |
ASTRAZENECA PLC | Corporate Officer/Principal | - |
Formación de Adrian Kilcoyne.
Warwick Business School | Graduate Degree |
University of London | Graduate Degree |
Trinity College Dublin | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 3 |
---|---|
ASTRAZENECA PLC | Health Technology |
HUMANIGEN, INC. | Health Technology |
CELULARITY INC. | Commercial Services |
- Bolsa de valores
- Insiders
- Adrian Kilcoyne